Chair of the Board since 2026, Chair of the Remuneration Committee.  

Born 1959.  

Thomas Axelsson has 40 years of experience within the Life Science industry, including serving as CEO of the publicly listed companies Vitrolife, Stille and Artema. He also has experience as a board member of listed companies such as MedCap and Medivir, as well as Chairman of several privately held companies, including Star Wine List and Nexpring Health. 

Thomas Axelsson studied Industrial Engineering and Management at Linköping University. 

Holdings in C-RAD: 0 Class B shares.